Paper39629124
BATF2 inhibits the stem cell-like properties and chemoresistance of gastric cancer cells through PTEN/AKT/β-catenin pathway.
Cao L and 12 others. Theranostics, 2024. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. BATF2 inhibits the stem cell-like properties and chemoresistance of gastric cancer cells through PTEN/AKT/β-catenin pathway. Papers, record 39629124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39629124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- BATF2 inhibits the stem cell-like properties and chemoresistance of gastric cancer cells through PTEN/AKT/β-catenin pathway.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Stomach Neoplasms | Major topic |
| PTEN Phosphohydrolase | Major topic |
| Neoplastic Stem Cells | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Basic-Leucine Zipper Transcription Factors | Major topic |
| beta Catenin | Major topic |
| Signal Transduction | Major topic |
| Humans | |
| Cell Line, Tumor | |
| Animals | |
| Mice | |
| Fluorouracil | |
| Gene Expression Regulation, Neoplastic | |
| ATP Binding Cassette Transporter, Subfamily G, Member 2 | |
| Tumor Suppressor Proteins | |
| Female | |
| Xenograft Model Antitumor Assays | |
| Male | |
| Mice, Nude | |
| Neoplasm Proteins |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 2 | 15803154 | Tumour stem cells and drug resistance. | Nat Rev Cancer | 2005 | https://conductscience.org/library/papers/15803154 | PubMed |
| 3 | 20531301 | Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1. | Oncogene | 2010 | https://conductscience.org/library/papers/20531301 | PubMed |
| 4 | 31110221 | Methylation and PTEN activation in dental pulp mesenchymal stem cells promotes osteogenesis and reduces oncogenesis. | Nat Commun | 2019 | https://conductscience.org/library/papers/31110221 | PubMed |
| 5 | 25957166 | Batf2/Irf1 induces inflammatory responses in classically activated macrophages, lipopolysaccharides, and mycobacterial infection. | J Immunol | 2015 | https://conductscience.org/library/papers/25957166 | PubMed |
| 6 | 38997271 | Increased ONECUT2 induced by Helicobacter pylori promotes gastric cancer cell stemness via an AKT-related pathway. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/38997271 | PubMed |
| 7 | 34857912 | A tumour-resident Lgr5+ stem-cell-like pool drives the establishment and progression of advanced gastric cancers. | Nat Cell Biol | 2021 | https://conductscience.org/library/papers/34857912 | PubMed |
| 8 | 33648498 | CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway. | Mol Cancer | 2021 | https://conductscience.org/library/papers/33648498 | PubMed |
| 9 | 30562741 | lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway. | Cell Physiol Biochem | 2018 | https://conductscience.org/library/papers/30562741 | PubMed |
| 10 | 28554189 | Structure of the human multidrug transporter ABCG2. | Nature | 2017 | https://conductscience.org/library/papers/28554189 | PubMed |
| 11 | 8570175 | B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family. | Oncogene | 1995 | https://conductscience.org/library/papers/8570175 | PubMed |
| 12 | 30228301 | Stem cell fate in cancer growth, progression and therapy resistance. | Nat Rev Cancer | 2018 | https://conductscience.org/library/papers/30228301 | PubMed |
| 13 | 35417031 | Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway. | Oncol Rep | 2022 | https://conductscience.org/library/papers/35417031 | PubMed |
| 14 | 27353863 | SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin. | Nat Commun | 2016 | https://conductscience.org/library/papers/27353863 | PubMed |
| 15 | 33436496 | PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells. | Gut | 2022 | https://conductscience.org/library/papers/33436496 | PubMed |
| 16 | 33671108 | The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33671108 | PubMed |
| 17 | 37777155 | BATF2 inhibits PD-L1 expression and regulates CD8+ T-cell infiltration in non-small cell lung cancer. | J Biol Chem | 2023 | https://conductscience.org/library/papers/37777155 | PubMed |
| 18 | 34282134 | Structures of ABCG2 under turnover conditions reveal a key step in the drug transport mechanism. | Nat Commun | 2021 | https://conductscience.org/library/papers/34282134 | PubMed |
| 19 | 32650804 | m6A modification-mediated BATF2 acts as a tumor suppressor in gastric cancer through inhibition of ERK signaling. | Mol Cancer | 2020 | https://conductscience.org/library/papers/32650804 | PubMed |
| 20 | 34217777 | DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer. | J Hepatol | 2021 | https://conductscience.org/library/papers/34217777 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42459646 | Decoding the PTM code of cGAS-STING in gastric cancer: from innate DNA sensing to precision combination therapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42459646 | PubMed |
| 42327781 | CDK4/6-targeted therapy for gastrointestinal cancers: from resistance mechanisms to immuno-combination strategies guided by biomarkers. | Front Immunol | 2026 | https://conductscience.org/library/papers/42327781 | PubMed |
| 42221812 | Integration of single-cell regulon atlas and bulk RNA-seq for individualized prognostic prediction in stomach adenocarcinoma. | iScience | 2026 | https://conductscience.org/library/papers/42221812 | PubMed |
| 41802813 | Hyaluronic acid-CD44 signaling defines therapeutic resistance and immunosuppressive microenvironment in peritoneal metastasis of gastric cancer. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41802813 | PubMed |
| 41761192 | MCM10, a novel YAP1/TEAD4 target, drives gastric cancer progression by bridging DNA replication to stemness acquisition. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41761192 | PubMed |
| 41725823 | Gastric cancer organoids: a promising model for personalized treatment of gastric cancer. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41725823 | PubMed |
| 41457098 | BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity. | Nat Commun | 2025 | https://conductscience.org/library/papers/41457098 | PubMed |
| 41127013 | Case Report: Failed response to anti-PD-1 immunotherapy in a colon cancer patient with high microsatellite instability. | Front Oncol | 2025 | https://conductscience.org/library/papers/41127013 | PubMed |
| 40765835 | Harnessing Natural Products to Surmount Drug Resistance in Gastric Cancer: Mechanisms and Therapeutic Perspectives. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/40765835 | PubMed |
| 40682844 | Role of exosomal non‑coding RNAs in cancer‑associated fibroblast‑mediated therapy resistance (Review). | Int J Oncol | 2025 | https://conductscience.org/library/papers/40682844 | PubMed |
| 40279682 | DNA-methylation eraser TET2 activates WTIP expression to suppress an AKT-dependent chemoresistance of gastric cancer. | Neoplasia | 2025 | https://conductscience.org/library/papers/40279682 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCG2 | 9429 | PubTator's text mining | https://conductscience.org/library/genes/9429 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| BATF2 | 116071 | PubTator's text mining | https://conductscience.org/library/genes/116071 | NCBI Gene |
| CD44 | 960 | PubTator's text mining | https://conductscience.org/library/genes/960 | NCBI Gene |
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| NANOG | 79923 | PubTator's text mining | https://conductscience.org/library/genes/79923 | NCBI Gene |
| PTEN | 5728 | PubTator's text mining | https://conductscience.org/library/genes/5728 | NCBI Gene |
| SOX2 | 6657 | PubTator's text mining | https://conductscience.org/library/genes/6657 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39629124
GET https://conductscience.org/api/papers/v1/39629124/references?page=2